TEMGESIC Side Effects

6558217-6 | Altered State Of Consciousness, Bronchopneumonia, Headache, Nausea, Pyrexia, Respiratory Failure
on Sep 30, 2009 Male patient from SWITZERLAND , 82 years of age, was treated with Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, bronchopneumonia, headache (What is headache?), nausea (What is nausea?), pyrexia, respiratory failure. Temgesic dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), TRANDATE (View Trandate Review and Trandate Label ). Patient was hospitalized.

6541864-5 | Abdominal Distension, Abdominal Pain, Bladder Cancer, Memory Impairment, Nausea, Overdose, Somnolence
Patient was taking Temgesic (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), bladder cancer (What is bladder cancer?), memory impairment, nausea (What is nausea?), overdose, somnolence on Jan 12, 2010 from FRANCE Additional patient health information: Male patient , 73 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Temgesic dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LASILIX (View Lasilix Review and Lasilix Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ), ADANCOR (View Adancor Review and Adancor Label ).

6427346-X | Abdominal Distension, Bladder Cancer, Nausea, Overdose, Somnolence
Adverse event was reported on Oct 29, 2009 by a Male patient taking Temgesic (View Usage) (Dosage: ) was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Location: FRANCE , 73 years of age, After Temgesic was administered, patient had the following side effects: abdominal distension, bladder cancer (What is bladder cancer?), nausea (What is nausea?), overdose, somnolence. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ).

6378095-8 | Altered State Of Consciousness
on Sep 22, 2009 Female patient from SWITZERLAND , 85 years of age, was diagnosed with pain (What is pain?) and was treated with Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness. Temgesic dosage: . During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), VITARUBIN (View Vitarubin Review and Vitarubin Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ), CALCIMAGON D3 (View Calcimagon-d3 Review and Calcimagon-d3 Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.


6366274-5 | Acute Myocardial Infarction, Angina Pectoris, Coronary Artery Stenosis
on Sep 10, 2009 Male patient from SWITZERLAND , 72 years of age, was treated with Temgesic (View Usage). Patient had the following side effects: acute myocardial infarction, angina pectoris, coronary artery stenosis. Temgesic dosage: . During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ), DOSPIR (View Dospir Review and Dospir Label ), LYRICA (View Lyrica Review and Lyrica Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), ELIXIR FRANGULAE (View Elixir Frangulae Review and Elixir Frangulae Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), APROVEL (View Aprovel Review and Aprovel Label ). Patient was hospitalized.

6327341-5 | Depressed Level Of Consciousness
Patient was taking Temgesic (View Usage). After Temgesic was administered, patient had the following side effects: depressed level of consciousness on Aug 21, 2009 from SWITZERLAND Additional patient health information: Male patient , 77 years of age, . Temgesic dosage: . During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ), INSULIN (View Insulin Review and Insulin Label ), LIQUAEMIN INJ (View Liquaemin Inj Review and Liquaemin Inj Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SORTIS (View Sortis Review and Sortis Label ), PLAVIX (View Plavix Review and Plavix Label ), LOPRESOR (View Lopresor Review and Lopresor Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

6184319-2 | Abnormal Behaviour, Confusional State, Hallucination, Visual, Logorrhoea, Overdose, Somnolence
Adverse event was reported on May 05, 2009 by a Male patient taking Temgesic (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: FRANCE , 58 years of age, Patient experienced the following unwanted or unexpected effects: abnormal behaviour, confusional state, hallucination, visual, logorrhoea, overdose, somnolence. During the same period patient was treated with BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6154960-1 | Confusional State, Urinary Tract Infection
on Apr 10, 2009 Male patient from SWEDEN , 83 years of age, was diagnosed with back pain (What is back pain?) and was treated with Temgesic (View Usage). Patient had the following side effects: confusional state, urinary tract infection (What is urinary tract infection?). Temgesic dosage: 0.2 Mg As Needed For Back Pain. During the same period patient was treated with NORSPAN (View Norspan Review and Norspan Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), FURIX (View Furix Review and Furix Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5938498-X | Dyspnoea, Hyperhidrosis, Nausea, Vertigo
on Oct 30, 2008 Male patient from ITALY , 83 years of age, was treated with Temgesic (View Usage). After Temgesic was administered, patient had the following side effects: dyspnoea, hyperhidrosis, nausea (What is nausea?), vertigo. Temgesic dosage: Unkown Dose And Frequency. Patient was hospitalized.

5843268-7 | Dementia
Patient was taking Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?) on Aug 12, 2008 from FRANCE Additional patient health information: Female patient , 81 years of age, . Temgesic dosage: . During the same period patient was treated with HYPERIUM (View Hyperium Review and Hyperium Label ), LOXEN (View Loxen Review and Loxen Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ).

5777418-8 | Coagulopathy, Feeling Hot, Hypotension
Adverse event was reported on Jun 16, 2008 by a Female patient taking Temgesic (View Usage) (Dosage: 0.2 Mg Every 10 To 12 Hours) was diagnosed with intervertebral disc injury and. Location: GERMANY , 77 years of age, Patient had the following side effects: coagulopathy, feeling hot, hypotension. During the same period patient was treated with NOVAMINSULFON (View Novaminsulfon Review and Novaminsulfon Label ), NITROLINGUAL (View Nitrolingual Review and Nitrolingual Label ), ISOPTIN 80 (View Isoptin 80 Review and Isoptin 80 Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), PERTENSO N (View Pertenso N Review and Pertenso N Label ).

5393253-7 | C-reactive Protein Increased, Confusional State, Haemodialysis, Hyperpyrexia, Hypotension, Hypoxia, Oxygen Saturation Decreased
on Jul 16, 2007 Female patient from SWITZERLAND , 65 years of age, was diagnosed with pain (What is pain?) and was treated with Temgesic (View Usage). After Temgesic was administered, patient had the following side effects: c-reactive protein increased, confusional state, haemodialysis, hyperpyrexia, hypotension, hypoxia, oxygen saturation decreased. Temgesic dosage: . During the same period patient was treated with DAFALGAN (View Dafalgan Review and Dafalgan Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), XANAX (View Xanax Review and Xanax Label ), NEXIUM (View Nexium Review and Nexium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5379600-0 | Mental Impairment
on Jul 02, 2007 Female patient from GERMANY , 80 years of age, was treated with Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: mental impairment. Temgesic dosage: .

5316401-3 | Dizziness, Hypertensive Crisis, Vomiting
Patient was taking Temgesic (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hypertensive crisis, vomiting on Apr 27, 2007 from GERMANY Additional patient health information: Female patient , 84 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Temgesic dosage: .

5308242-8 | Incontinence, Pollakiuria, Speech Disorder
Adverse event was reported on Apr 18, 2007 by a Female patient taking Temgesic (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: DENMARK , 37 years of age, After Temgesic was administered, patient had the following side effects: incontinence, pollakiuria, speech disorder. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), IMOZOG (View Imozog Review and Imozog Label ), SETRALIN (View Setralin Review and Setralin Label ), MITRAZAPIN (View Mitrazapin Review and Mitrazapin Label ), PAMOL (View Pamol Review and Pamol Label ).

5308215-5 | Congestive Cardiomyopathy, Hyperthyroidism
on Apr 10, 2007 Male patient from FRANCE , 83 years of age, was diagnosed with brain neoplasm, myocardial infarction, essential hypertension and was treated with Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: congestive cardiomyopathy, hyperthyroidism. Temgesic dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ). Patient was hospitalized.

5307998-8 | Hyperthyroidism
on Apr 10, 2007 Male patient from FRANCE , 83 years of age, was diagnosed with essential hypertension and was treated with Temgesic (View Usage). Patient had the following side effects: hyperthyroidism. Temgesic dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ). Patient was hospitalized.

5306782-9 | Hyperthyroidism
Patient was taking Temgesic (View Usage). After Temgesic was administered, patient had the following side effects: hyperthyroidism on Apr 10, 2007 from FRANCE Additional patient health information: Male patient , 83 years of age, was diagnosed with essential hypertension and. Temgesic dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ). Patient was hospitalized.

5305283-1 | Incontinence, Pollakiuria, Speech Disorder
Adverse event was reported on Apr 18, 2007 by a Female patient taking Temgesic (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: DENMARK , 37 years of age, Patient experienced the following unwanted or unexpected effects: incontinence, pollakiuria, speech disorder. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), IMOZOG (View Imozog Review and Imozog Label ), SETRALIN (View Setralin Review and Setralin Label ), MITRAZAPIN (View Mitrazapin Review and Mitrazapin Label ), PAMOL (View Pamol Review and Pamol Label ).

5305278-8 | Hyperthyroidism
on Apr 10, 2007 Male patient from FRANCE , 83 years of age, was diagnosed with essential hypertension and was treated with Temgesic (View Usage). Patient had the following side effects: hyperthyroidism. Temgesic dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ). Patient was hospitalized.

5305235-1 | Incontinence, Pollakiuria, Speech Disorder
on Apr 18, 2007 Female patient from DENMARK , 37 years of age, was diagnosed with pain (What is pain?) and was treated with Temgesic (View Usage). After Temgesic was administered, patient had the following side effects: incontinence, pollakiuria, speech disorder. Temgesic dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), IMOZOG (View Imozog Review and Imozog Label ), SETRALIN (View Setralin Review and Setralin Label ), MITRAZAPIN (View Mitrazapin Review and Mitrazapin Label ), PAMOL (View Pamol Review and Pamol Label ).

5305232-6 | Hyperthyroidism
Patient was taking Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: hyperthyroidism on Apr 10, 2007 from FRANCE Additional patient health information: Male patient , 83 years of age, was diagnosed with essential hypertension and. Temgesic dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ). Patient was hospitalized.

5304113-1 | Incontinence, Pollakiuria, Speech Disorder
Adverse event was reported on Apr 18, 2007 by a Female patient taking Temgesic (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: DENMARK , 37 years of age, Patient had the following side effects: incontinence, pollakiuria, speech disorder. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), IMOZOG (View Imozog Review and Imozog Label ), SETRALIN (View Setralin Review and Setralin Label ), MITRAZAPIN (View Mitrazapin Review and Mitrazapin Label ), PAMOL (View Pamol Review and Pamol Label ).

5302830-0 | Hyperthyroidism
on Apr 10, 2007 Male patient from FRANCE , 83 years of age, was diagnosed with essential hypertension and was treated with Temgesic (View Usage). After Temgesic was administered, patient had the following side effects: hyperthyroidism. Temgesic dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ). Patient was hospitalized.

5291604-5 | Incontinence, Pollakiuria, Speech Disorder
on Apr 04, 2007 Female patient from DENMARK , 37 years of age, was diagnosed with pain (What is pain?) and was treated with Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: incontinence, pollakiuria, speech disorder. Temgesic dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), IMOZOG (View Imozog Review and Imozog Label ), SETRALIN (View Setralin Review and Setralin Label ), MITRAZAPIN (View Mitrazapin Review and Mitrazapin Label ), PAMOL (View Pamol Review and Pamol Label ).

5240175-8 | Confusional State, Disorientation, Fatigue, Hallucination, Insomnia, Somnolence
Patient was taking Temgesic (View Usage). Patient had the following side effects: confusional state, disorientation, fatigue, hallucination, insomnia, somnolence on Feb 14, 2007 from SWITZERLAND Additional patient health information: Male patient , 93 years of age, weighting 160.9 lb, was diagnosed with delirium, depression (What is depression?) and. Temgesic dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), XATRAL (View Xatral Review and Xatral Label ), BRUFEN (View Brufen Review and Brufen Label ), SURMONTIL (View Surmontil Review and Surmontil Label ), CIPRALEX (View Cipralex Review and Cipralex Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ). Patient was hospitalized.

5238217-9 | Hyperthyroidism
Adverse event was reported on Jan 26, 2007 by a Male patient taking Temgesic (View Usage) (Dosage: ) was diagnosed with essential hypertension and. Location: FRANCE , 83 years of age, After Temgesic was administered, patient had the following side effects: hyperthyroidism. During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), MOPRAL (View Mopral Review and Mopral Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ). Patient was hospitalized.

5160106-9 | Dizziness, Visual Acuity Reduced
on Nov 23, 2006 Male patient from GERMANY , 49 years of age, was diagnosed with pain (What is pain?) and was treated with Temgesic (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), visual acuity reduced. Temgesic dosage: .

5158307-9 | Dizziness, Visual Acuity Reduced
on Nov 23, 2006 Male patient from GERMANY , 49 years of age, was diagnosed with pain (What is pain?) and was treated with Temgesic (View Usage). Patient had the following side effects: dizziness (What is dizziness?), visual acuity reduced. Temgesic dosage: .

4646192-0 | Arthralgia, Arthritis Bacterial, Atrial Fibrillation, Blood Creatinine Increased, Bronchopneumonia, Cardiac Failure, Cholestasis, Hallucination, Renal Failure
Patient was taking Temgesic (View Usage). After Temgesic was administered, patient had the following side effects: arthralgia, arthritis bacterial, atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, bronchopneumonia, cardiac failure, cholestasis, hallucination, renal failure on Apr 15, 2005 from Additional patient health information: Male patient , 44 years of age, was diagnosed with pain (What is pain?), renal transplant, anxiety disorder and. Temgesic dosage: 0.2 - 0.6 Mg/d. During the same period patient was treated with PREDNISONE (10 Mg/d) (View Prednisone Review and Prednisone Label ), TEMESTA (2 Mg/d) (View Temesta Review and Temesta Label ), SANDIMMUNE (175 Mg/d) (View Sandimmune Review and Sandimmune Label ), CELLCEPT (1000 Mg/d) (View Cellcept Review and Cellcept Label ), RECORMON (10000 Iu, Qw3) (View Recormon Review and Recormon Label ), FOLIC ACID (5 Mg/d) (View Folic Acid Review and Folic Acid Label ), FRAXIPARINE (0.3 Ml/d) (View Fraxiparine Review and Fraxiparine Label ), DAFALGAN (4000 G/d) (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

4642137-8 | Arthralgia, Arthritis Bacterial, Atrial Fibrillation, Blood Creatinine Increased, Bronchopneumonia, Cardiac Failure, Cholestasis, Hallucination, Hallucinations, Mixed
Adverse event was reported on Apr 15, 2005 by a Male patient taking Temgesic (View Usage) (Dosage: 0.6 Mg/d) was diagnosed with renal transplant and. Location: , 44 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis bacterial, atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, bronchopneumonia, cardiac failure, cholestasis, hallucination, hallucinations, mixed. During the same period patient was treated with PREDNISONE TAB (10 Mg/d) (View Prednisone Tab Review and Prednisone Tab Label ), TEMESTA (2 Mg/d) (View Temesta Review and Temesta Label ), SANDIMMUNE (175 Mg/d) (View Sandimmune Review and Sandimmune Label ), CELLCEPT (1000 Mg/d) (View Cellcept Review and Cellcept Label ), RECORMON (10000 Iu, Qw3) (View Recormon Review and Recormon Label ), FOLIC ACID (5 Mg/d) (View Folic Acid Review and Folic Acid Label ), FRAXIPARINE (0.3 Ml/d) (View Fraxiparine Review and Fraxiparine Label ), DAFALGAN (4000 G/d) (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.